<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03454594</url>
  </required_header>
  <id_info>
    <org_study_id>P.T.REC/012/001561</org_study_id>
    <nct_id>NCT03454594</nct_id>
  </id_info>
  <brief_title>Nasal / Wrist Acupuncture Laser Radiation for Hypertensive and High Blood Viscosity Patients</brief_title>
  <official_title>Laser Hemotherapy Trial for Coronary Artery Disease High Risk Hypertensive Patient With High Blood Viscosity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effect of low level laser blood radiation applied to all
      participants in the treatment and controlling high blood pressure and high blood viscosity as
      well
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The areas of low - intensity laser use have expanded in several conditions by different
      mechanisms and ways. Hypertension as one of coronary artery disease risk factors and early
      indicator of future cardiovascular events with high blood viscosity became necessary issue to
      be handled. Low Level Laser irradiation effects on blood is very essential way in revealing
      the mechanisms of the action of laser radiation on biological tissues by means of changes in
      metabolism, leading to molecular, cellular and systemic changes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes of blood pressure</measure>
    <time_frame>8 weeks</time_frame>
    <description>measuring blood pressure before and after each low level laser radiation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in blood viscosity</measure>
    <time_frame>8 weeks</time_frame>
    <description>measuring changes in blood viscosity before and after low level laser radiation session</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>low level laser hemotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>nasal and wrist low level laser irradiation applied for 30 min with the highest power twice per week for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>low level laser hemotherapy</intervention_name>
    <description>semiconductor laser therapeutic instrument irradiate the circulating blood in the vessels of left hand acupoint and the mucosal tissue in the nasal cavity</description>
    <arm_group_label>low level laser hemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stage II hypertensive patients

          -  patients from 30 to 34.9 kg/m2 body mass index

          -  medically stable patients

        Exclusion Criteria:

          -  history of malignant disease

          -  smoking

          -  history of progressive fatal disease

          -  history of drug or alcohol abuse

          -  blood donation within at least 30 days

          -  pregnant, trying to be pregnant or breast feeding

          -  cognitive impairment that will make it difficult to partake in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cairo Giza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ebtesam N Nagy, MD</last_name>
    <phone>+201278141946</phone>
    <email>Dr.EbtesamNagy@outlook.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo</name>
      <address>
        <city>Giza</city>
        <state>Dokki</state>
        <zip>11432</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ebtesam N Nagy</last_name>
      <phone>+201278141946</phone>
      <email>Dr.EbtesamNagy@outlook.com</email>
    </contact>
    <investigator>
      <last_name>Ebtesam N Nagy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2018</study_first_submitted>
  <study_first_submitted_qc>March 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>March 3, 2018</last_update_submitted>
  <last_update_submitted_qc>March 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ebtesam Nabil</investigator_full_name>
    <investigator_title>lecturer assistance at Cairo University</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>high blood viscosity</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

